Answers are grounded in this paper and cite their sources.
Compares pregnancy outcomes between short and long protocols in women undergoing IVF, suggesting both are effective.
This study sought to evaluate whether a short or long protocol would be preferable for simplification of a fixed-schedule for in vitro fertilization and embryo transfer (IVF-ET) program without negatively affecting the pregnancy rate per cycle. All women were allocated, according to the ovarian stimulation protocol, into two groups. In Group 1 for the short protocol (41 occasions), the patients were treated with human menopausal gonadotropin (hMG) before pituitary desensitization using buserelin from cycle day 1. In the Group 2 for the long protocol (106 occasions), the patients received hMG after pituitary desensitization achieved with buserelin. The day and time of ovum pickup (OPU) was fixed as a Wednesday. Ovarian stimulation was started on Monday, 10 days before the day of OPU, with a daily dose of 225 IU/hMG for the following 7 days. Ovulation was induced with human chorionic gonadotropin (hCG) on Tuesday, and OPU was performed on Wednesday; ET was carried out on Friday. No significant differences were found between the two groups in the incidence of canceled cycles [group 1: 7.3 %(3/41), group 2: 2.8 %(3/106)], mean number of oocytes recovered (6.4 ±4.0, 5.8 ±5.1), the fertilization rate [40.6 %(106/261), 44.3 %(272/614)], or the pregnancy rate per cycle [19.5 %(8/41), 18.9 %(20/106)]. These findings indicate that treatment with buserelin/hMG/hCG with either a short or long protocol is useful for a fixed-schedule IVF-ET program.
No takes yet. Share an insight, caveat, or question.
A 1999 study studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: